Insider Transactions in Q4 2017 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q4 2017)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 05
2017
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,058
-42.79%
|
$42,812
$14.44 P/Share
|
Dec 05
2017
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,860
+45.06%
|
-
|
Dec 01
2017
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,730
-6.93%
|
$38,220
$14.33 P/Share
|
Dec 01
2017
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,450
+17.67%
|
-
|
Nov 01
2017
|
Eric Mosbrooker SVP, Orphan Business Unit |
SELL
Payment of exercise price or tax liability
|
Direct |
2,315
-39.24%
|
$30,095
$13.83 P/Share
|
Nov 01
2017
|
Eric Mosbrooker SVP, Orphan Business Unit |
BUY
Exercise of conversion of derivative security
|
Direct |
4,435
+42.91%
|
-
|
Oct 25
2017
|
David Happel EVP, Commercial Dev & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-44.92%
|
$53,950
$13.53 P/Share
|
Oct 25
2017
|
David Happel EVP, Commercial Dev & Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
7,953
+46.26%
|
-
|